VT News

Paul Fletcher

Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
  • Carlsberg's Q1 sales miss expectations, but the company maintains its full-year guidance amid global economic risks.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
  • Carlsberg's Q1 sales miss expectations, but the company maintains its full-year guidance amid global economic risks.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Paul Fletcher

Top Topics

Trending in U.S.

World

Sport